| Medical and Health Sciences | Lifetime | 703 | DE 28 | 99.97 |
| Agricultural, Food and Veterinary Sciences | Lifetime | 595 | DE 23 | 99.52 |
| Epidemiology | Lifetime | 20 | DE 1 | 99.97 |
| Infectious Diseases | Lifetime | 64 | DE 4 | 99.78 |
| Animal Science and Livestock Production | Lifetime | 115 | DE 1 | 99.12 |
| Public, Environmental and Occupational Health | Lifetime | 912 | DE 17 | 98.68 |
| Immunology | Lifetime | 613 | DE 43 | 98.18 |
| Virology | Lifetime | 137 | DE 3 | 97.56 |
| Agronomy and Crop Science | Lifetime | 435 | DE 13 | 97.17 |
| Hepatology | Lifetime | 702 | DE 29 | 88.19 |
| Parasitology | Lifetime | 678 | DE 25 | 84.45 |
| SARS-CoV-2 and COVID-19 Research | Lifetime | 7 | DE 2 | 99.92 |
| Respiratory viral infections research | Lifetime | 5 | DE 1 | 99.94 |
| Virology and Viral Diseases | Lifetime | 3 | DE 1 | 99.87 |
| Animal Virus Infections Studies | Lifetime | 8 | DE 1 | 99.88 |
| Influenza Virus Research Studies | Lifetime | 8 | DE 1 | 99.93 |
| Viral gastroenteritis research and epidemiology | Lifetime | 17 | DE 1 | 99.90 |
| Animal Disease Management and Epidemiology | Lifetime | 13 | DE 2 | 99.81 |
| Viral Infections and Vectors | Lifetime | 52 | DE 2 | 99.68 |
| Virus-based gene therapy research | Lifetime | 99 | DE 3 | 99.55 |
| COVID-19 Clinical Research Studies | Lifetime | 134 | DE 7 | 99.23 |
| Herpesvirus Infections and Treatments | Lifetime | 63 | DE 4 | 99.36 |
| Viral Infections and Immunology Research | Lifetime | 192 | DE 13 | 98.65 |
| Viral Infections and Outbreaks Research | Lifetime | 100 | DE 5 | 98.87 |
| Immune Cell Function and Interaction | Lifetime | 691 | DE 40 | 99.11 |
| Immune Response and Inflammation | Lifetime | 380 | DE 29 | 99.01 |
| Hepatitis B Virus Studies | Lifetime | 395 | DE 30 | 98.90 |
| HIV Research and Treatment | Lifetime | 367 | DE 10 | 99.00 |
| Cytomegalovirus and herpesvirus research | Lifetime | 299 | DE 17 | 98.48 |
| Mosquito-borne diseases and control | Lifetime | 573 | DE 13 | 98.39 |
| Immunotherapy and Immune Responses | Lifetime | 987 | DE 83 | 98.51 |
| vaccines and immunoinformatics approaches | Lifetime | 173 | DE 13 | 97.82 |
| COVID-19 epidemiological studies | Lifetime | 360 | DE 7 | 97.41 |
| Parvovirus B19 Infection Studies | Lifetime | 210 | DE 16 | 97.55 |
| Zoonotic diseases and public health | Lifetime | 222 | DE 4 | 96.97 |
| HIV/AIDS drug development and treatment | Lifetime | 770 | DE 28 | 97.62 |
| Marine animal studies overview | Lifetime | 456 | DE 19 | 97.25 |
| Poxvirus research and outbreaks | Lifetime | 155 | DE 6 | 96.46 |
| Immunodeficiency and Autoimmune Disorders | Lifetime | 889 | DE 53 | 96.69 |
| Rabies epidemiology and control | Lifetime | 266 | DE 10 | 96.50 |
| Immune responses and vaccinations | Lifetime | 138 | DE 9 | 95.10 |
| Toxoplasma gondii Research Studies | Lifetime | 319 | DE 20 | 96.32 |
| Vaccine Coverage and Hesitancy | Lifetime | 683 | DE 15 | 96.07 |
| Hepatitis Viruses Studies and Epidemiology | Lifetime | 516 | DE 32 | 95.47 |
| Travel-related health issues | Lifetime | 812 | DE 46 | 80.51 |
